Showing results (2001-2010 of 8,157) with videos related to
Sort By:
Pageof 816
Haematologica|August 27, 2026
Response to Comment on: "Treatment of therapy-related acute myeloid leukemia and acute myeloid leukemia with myelodysplasiarelated changes: a comparative analysis of higher-dose intensive 7+3 induction chemotherapy versus liposomal cytarabine and daunorubicin"Dimitrios Kotsos, Jurjen VersluisHaematologica|September 3, 2026
Independent prognostic value of semaphorin-4D, interleukin-1β and complement activation in newly diagnosed multiple myeloma patientsIoannis Ntanasis-Stathopoulos, Panagiota-Efstathia Nikolaou, Charalampos Filippatos, et al.Haematologica|September 3, 2026
Gilteritinib plus azacitidine in patients with newly diagnosed FLT3 mutation-positive acute myeloid leukemia who were ineligible for intensive chemotherapy: final results of the phase III LACEWING studyEunice S Wang, Pau Montesinos, Mark D Minden, et al.Haematologica|September 3, 2026
Real-world minimal residual disease assessment in multiple myeloma using a standardized flow cytometry approach: feasibility, clinical implications, and immune correlates from a single-center experienceCirino Botta, Andrea Rizzuto, Maria Speciale, et al.Haematologica|September 3, 2026
Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trialsDouglas Tremblay, Li Chen, Zhuoxin Sun, et al.Haematologica|September 3, 2026
Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myelomaMarie Christine Wesener, Uta Margareta Demel, Thomas Pabst, et al.Haematologica|September 3, 2026
Measurable residual KMT2A partial tandem duplication before allogeneic stem cell transplantation in acute myeloid leukemiaLulu Wang, Haixia Fu, Yazhen Qin, et al.Haematologica|September 3, 2026
Single-cell RNA editing identifies aggressive and favorable cellular states in chronic myelomonocytic leukemiaNisansala Wickramasinghe, Doan Bui, Surendra Neupane, et al.Haematologica|September 10, 2026
Does it really have to hurt? All-oral treatment for acute myeloid leukemiaChristoph Rummelt, Michael LübbertHaematologica|September 10, 2026
Excess mortality convergence after paediatric allogeneic transplantation: a caveat for the right to be forgotten. Comment on: "Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia"Tang-Her Jaing, Yi-Lun WangPageof 816